• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保护人类声音:呼吁规范ChatGPT在书信和观点写作中的使用。

Preserving the human voice: A plea for regulating ChatGPT use in Correspondence and Opinion writing.

作者信息

Matsubara Shigeki

机构信息

Department of Obstetrics and Gynaecology, Jichi Medical University, Tochigi, Japan.

Department of Obstetrics and Gynaecology, Koga Red Cross Hospital, Koga, Ibaraki, Japan.

出版信息

Aust N Z J Obstet Gynaecol. 2025 Apr;65(2):293-296. doi: 10.1111/ajo.13877. Epub 2024 Sep 4.

DOI:10.1111/ajo.13877
PMID:39231760
Abstract

Correspondence and Opinion provide a 'human voice,' serving as the captivating elements that grab readers' attention and stimulate contemplation. The extent of ChatGPT's involvement in writing raises controversy. We tested ChatGPT's capability to generate readable Correspondence or Opinion, producing an English Opinion from a Japanese abstract. We also tasked ChatGPT with creating Correspondence and Reply for an English→German translated Opinion. Opinion, Correspondence, and Reply output here were found to be readable and reasonable. While preliminary, these results suggest that ChatGPT can generate such articles, prompting serious concern about AI taking over the 'human voice.' Some regulatory measures may be needed.

摘要

信函和观点提供了一种“人类的声音”,是吸引读者注意力并激发思考的引人入胜的元素。ChatGPT在写作中所涉及的程度引发了争议。我们测试了ChatGPT生成可读性信函或观点的能力,从一篇日文摘要生成了一篇英文观点。我们还让ChatGPT为一篇从英文翻译成德文的观点创建信函和回复。此处生成的观点、信函和回复被发现具有可读性且合理。虽然这些结果只是初步的,但它们表明ChatGPT可以生成此类文章,这引发了对人工智能取代“人类声音”的严重担忧。可能需要一些监管措施。

相似文献

1
Preserving the human voice: A plea for regulating ChatGPT use in Correspondence and Opinion writing.保护人类声音:呼吁规范ChatGPT在书信和观点写作中的使用。
Aust N Z J Obstet Gynaecol. 2025 Apr;65(2):293-296. doi: 10.1111/ajo.13877. Epub 2024 Sep 4.
2
Letters generated by ChatGPT: Author who?由 ChatGPT 生成的信件:作者是谁?
J Obstet Gynaecol Res. 2024 Jul;50(7):1250-1252. doi: 10.1111/jog.15948. Epub 2024 Apr 8.
3
Comparing letters written by humans and ChatGPT: A preliminary study.比较人类与ChatGPT撰写的信件:一项初步研究。
Int J Gynaecol Obstet. 2025 Jan;168(1):320-325. doi: 10.1002/ijgo.15827. Epub 2024 Jul 31.
4
How much can we rely on artificial intelligence chatbots such as the ChatGPT software program to assist with scientific writing?我们能在多大程度上依靠诸如ChatGPT软件程序这样的人工智能聊天机器人来辅助科学写作?
J Prosthet Dent. 2025 Apr;133(4):1082-1088. doi: 10.1016/j.prosdent.2023.05.023. Epub 2023 Jul 10.
5
Could artificial intelligence write mental health nursing care plans?人工智能能写心理健康护理计划吗?
J Psychiatr Ment Health Nurs. 2024 Feb;31(1):79-86. doi: 10.1111/jpm.12965. Epub 2023 Aug 4.
6
[Human vs. ChatGPT. Is it possible obtain comparable results in the analysis of a scientific systematic review?].[人类与ChatGPT。在科学系统评价分析中有可能获得可比结果吗?]
Recenti Prog Med. 2024 Sep;115(9):420-425. doi: 10.1701/4334.43184.
7
What's the difference between human-written manuscripts versus ChatGPT-generated manuscripts involving "human touch"?
J Obstet Gynaecol Res. 2025 Feb;51(2):e16226. doi: 10.1111/jog.16226.
8
A thorough examination of ChatGPT-3.5 potential applications in medical writing: A preliminary study.全面探讨 ChatGPT-3.5 在医学写作中的潜在应用:一项初步研究。
Medicine (Baltimore). 2024 Oct 4;103(40):e39757. doi: 10.1097/MD.0000000000039757.
9
ChatGPT's Ability to Assess Quality and Readability of Online Medical Information: Evidence From a Cross-Sectional Study.ChatGPT评估在线医学信息质量和可读性的能力:一项横断面研究的证据。
Cureus. 2023 Jul 20;15(7):e42214. doi: 10.7759/cureus.42214. eCollection 2023 Jul.
10
ChatGPT's performance in German OB/GYN exams - paving the way for AI-enhanced medical education and clinical practice.ChatGPT在德国妇产科考试中的表现——为人工智能强化医学教育和临床实践铺平道路。
Front Med (Lausanne). 2023 Dec 13;10:1296615. doi: 10.3389/fmed.2023.1296615. eCollection 2023.